J&J submits FDA application for myasthenia gravis drug nipocalimab08/30/2024 J&J submits FDA application for myasthenia gravis drug nipocalimab Source: Seekingalpha
FDA accepts SpringWorks' application for mirdametinib for NF1-PN08/29/2024 FDA accepts SpringWorks’ application for mirdametinib for NF1-PN Source: Seekingalpha